As RASopathies can disrupt the nervous system, causing different movement- and learning-associated symptoms, it is important to understand how hyperactivation of MEK1 – which would subsequently cause aberrant activation of downstream proteins in the RAS pathway – affects neuronal cells. The gene discussed is MAP2K1; the disease is RASopathy.